4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
HLS Therapeutics Inc. (HLS) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Etobicoke, Canada with about 85 employees. Its market capitalization is roughly $122 million. In the fiscal year ended 2025-12-31, HLS reported $56M in revenue and ($12M) in net income.
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $56M | $57M | $63M | $62M | — |
| Gross Profit | $45M | $48M | $56M | $56M | — |
| Operating Income (EBIT) | ($4M) | ($8M) | ($10M) | ($14M) | — |
| Net Income | ($12M) | ($20M) | ($28M) | ($24M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $13M | $15M | $14M | $14M | $13M | — |
| Gross Profit | $10M | $13M | $11M | $12M | $10M | — |
| Operating Income (EBIT) | ($2M) | $0M | ($1M) | ($1M) | ($2M) | — |
| Net Income | ($2M) | ($1M) | ($4M) | ($3M) | ($4M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | $0M | ($2M) | ($5M) | ($5M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | — | — | — | — | — | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $138M | $160M | $209M | $242M | — |
| Total Liabilities | $76M | $89M | $111M | $116M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HLS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms